BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 87 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q3 2020. The put-call ratio across all filers is 1.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4 | -90.2% | 20,000 | 0.0% | 0.00% | – |
| Q2 2023 | $41 | +24.2% | 20,000 | 0.0% | 0.00% | – |
| Q4 2022 | $33 | -100.0% | 20,000 | 0.0% | 0.00% | – |
| Q3 2022 | $88,000 | -7.4% | 20,000 | -4.3% | 0.00% | – |
| Q4 2020 | $95,000 | -74.3% | 20,890 | -4.6% | 0.00% | -100.0% |
| Q3 2020 | $370,000 | +203.3% | 21,890 | +101.0% | 0.00% | +100.0% |
| Q2 2020 | $122,000 | +154.2% | 10,890 | +4.7% | 0.00% | – |
| Q1 2020 | $48,000 | – | 10,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 189,935 | $311,494 | 0.08% |
| ABNER HERRMAN & BROCK LLC | 280,000 | $459 | 0.07% |
| Weaver Consulting Group | 65,947 | $108,153 | 0.06% |
| S.C. Financial Services, Inc. | 25,372 | $41,610 | 0.03% |
| JMAC ENTERPRISES LLC | 40,430 | $66,305 | 0.02% |
| Weaver Consulting Group | 53,500 | $10,047 | 0.01% |
| IFP Advisors, Inc | 26,650 | $139 | 0.00% |
| Bangor Savings Bank | 4,000 | $7 | 0.00% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 3,000 | $4,920 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 19,098 | $31,321 | 0.00% |